Litcius/Paper detail

OX40 enhances T cell immune response to PD-1 blockade therapy in non-small cell lung cancer

Juanfeng Lao, Can Cao, Xiaoli Niu, Simei Deng, Siqi Ming, Siping Liang, Yuqi Shang, Yulin Yuan, Xiaomin Shi, Zibin Liang, Minhao Wu, Yongjian Wu

2022International Immunopharmacology16 citationsDOI

Topics & Concepts

ImmunotherapyLung cancerMedicineT cellBlockadeImmune systemCancer researchCancer immunotherapyCombination therapyCancerEx vivoImmune checkpointImmunologyIn vivoPharmacologyReceptorOncologyInternal medicineBiologyBiotechnologyCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesImmune Cell Function and Interaction
OX40 enhances T cell immune response to PD-1 blockade therapy in non-small cell lung cancer | Litcius